In a study by El-Akhras and colleagues in patients with SLE, they found that miR-146a was significantly increased in peripheral blood mononuclear cells (PBMC) and correlated positively with IL-6; based on these findings, they considered it a marketable marker for this autoimmune disease [83]. Here, IL6 is linked to autoimmune disease.